Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

February 01, 2019; Volume 368,Issue 2

Minireviews

  • You have access
    Anti-Claudin Antibodies as a Concept for Development of Claudin-Directed Drugs
    Yosuke Hashimoto, Yoshiaki Okada, Keisuke Shirakura, Keisuke Tachibana, Makoto Sawada, Kiyohito Yagi, Takefumi Doi and Masuo Kondoh
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 179-186; DOI: https://doi.org/10.1124/jpet.118.252361

Behavioral Pharmacology

  • You have access
    Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice
    Catheryn D. Wilson, Sherrica Tai, Laura Ewing, Jasmine Crane, Taylor Lockhart, Ryochi Fujiwara, Anna Radominska-Pandya and William E. Fantegrossi
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 146-156; DOI: https://doi.org/10.1124/jpet.118.251157
  • You have access
    Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys
    Lisa R. Gerak, David R. Maguire, James H. Woods, Stephen M. Husbands, Alex Disney and Charles P. France
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 229-236; DOI: https://doi.org/10.1124/jpet.118.253286

Cardiovascular

  • You have access
    Protective Effects of Duloxetine against Cerebral Ischemia-Reperfusion Injury via Transient Receptor Potential Melastatin 2 Inhibition
    Takahiro Toda, Shinichiro Yamamoto, Noriko Umehara, Yasuo Mori, Minoru Wakamori and Shunichi Shimizu
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 246-254; DOI: https://doi.org/10.1124/jpet.118.253922

Cellular and Molecular

  • You have access
    Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivatives
    Hilary E. Nicholson, Walid F. Alsharif, Anthony B. Comeau, Christophe Mesangeau, Sebastiano Intagliata, Marco Mottinelli, Christopher R. McCurdy and Wayne D. Bowen
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 272-281; DOI: https://doi.org/10.1124/jpet.118.253484

Drug Discovery and Translational Medicine

  • You have access
    Development of Human Target Validation Classification that Predicts Future Clinical Efficacy
    Cecilia Karlsson, Peter J. Greasley, David Gustafsson and Karin Wåhlander
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 255-261; DOI: https://doi.org/10.1124/jpet.118.250894
  • You have access
    A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats
    Michael D. Raleigh, Federico Baruffaldi, Samantha J. Peterson, Morgan Le Naour, Theresa M. Harmon, Jennifer R. Vigliaturo, Paul R. Pentel and Marco Pravetoni
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 282-291; DOI: https://doi.org/10.1124/jpet.118.253674

Endocrine and Diabetes

  • You have access
    Estrogen-Dependent Disruption of Adiponectin-Connexin43 Signaling Underlies Exacerbated Myocardial Dysfunction in Diabetic Female Rats
    Korin E. Leffler and Abdel A. Abdel-Rahman
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 208-217; DOI: https://doi.org/10.1124/jpet.118.254029
  • You have access
    α-Tocopherol Potentiates the Cervical Resistance Decreasing Effects of COX Inhibitors in Pregnant Rats: The Putative Role of Cyclooxygenase-2 Inhibition
    Anna Kothencz, Judit Hajagos-Tóth, Kálmán F. Szűcs, Annamária Schaffer and Róbert Gáspár
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 292-298; DOI: https://doi.org/10.1124/jpet.118.251850

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Diuretic, Natriuretic, and Vasodepressor Activity of a Lipid Fraction Enhanced in Medium of Cultured Mouse Medullary Interstitial Cells by a Selective Fatty Acid Amide Hydrolase Inhibitor
    Zdravka Daneva, Sara K. Dempsey, Ashfaq Ahmad, Ningjun Li, Pin-Lan Li and Joseph K. Ritter
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 187-198; DOI: https://doi.org/10.1124/jpet.118.252320
  • You have access
    Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity
    John P. Russell, Ehsan Mohammadi, Casey O. Ligon, Anthony C. Johnson, Michael D. Gershon, Meenakshi Rao, Yuhong Shen, Chi-Chung Chan, Hilary S. Eidam, Michael P. DeMartino, Mui Cheung, Allen I. Oliff, Sanjay Kumar and Beverley Greenwood-Van Meerveld
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 299-307; DOI: https://doi.org/10.1124/jpet.118.252973

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes
    Afshin Ebrahimpour, Samana Shrestha, Mark D. Bonnen, N. Tony Eissa, Ganesh Raghu and Yohannes T. Ghebre
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 169-178; DOI: https://doi.org/10.1124/jpet.118.252650
  • Dihydromyricetin Inhibits Inflammation of Fibroblast-Like Synoviocytes through Regulation of Nuclear Factor-<em>κ</em>B Signaling in Rats with Collagen-Induced Arthritis
    You have access
    Dihydromyricetin Inhibits Inflammation of Fibroblast-Like Synoviocytes through Regulation of Nuclear Factor-κB Signaling in Rats with Collagen-Induced Arthritis
    Jing Wu, Fu-Tao Zhao, Kai-Jian Fan, Jun Zhang, Bing-Xing Xu, Qi-Shan Wang, Ting-Ting Tang and Ting-Yu Wang
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 218-228; DOI: https://doi.org/10.1124/jpet.118.253369

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance
    Takanobu Matsuzaki, Daniel Scotcher, Adam S. Darwich, Aleksandra Galetin and Amin Rostami-Hodjegan
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 157-168; DOI: https://doi.org/10.1124/jpet.118.251413
  • You have access
    Alterations in Xenobiotic-Metabolizing Enzyme Activities across Menstrual Cycle in Healthy Volunteers
    E. Asprodini, V. Tsiokou, E. Begas, T. Kilindris, E. Kouvaras, M. Samara and I. Messinis
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 262-271; DOI: https://doi.org/10.1124/jpet.118.254284
  • You have access
    Influence of Stereochemistry on the Bioactivation and Glucuronidation of 4-Ipomeanol
    Aaron M. Teitelbaum, Matthew G. McDonald, John P. Kowalski, Oliver T. Parkinson, Michele Scian, Dale Whittington, Katharina Roellecke, Helmut Hanenberg, Constanze Wiek and Allan E. Rettie
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 308-316; DOI: https://doi.org/10.1124/jpet.118.249771
  • You have access
    Experimental Evidence for Resecretion of PGE2 across Rat Alveolar Epithelium by OATP2A1/SLCO2A1-Mediated Transcellular Transport
    Takeo Nakanishi, Hiroki Takashima, Yuka Uetoko, Hisakazu Komori and Ikumi Tamai
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 317-325; DOI: https://doi.org/10.1124/jpet.118.249789

Neuropharmacology

  • You have access
    A Comparative Study of the Pharmacokinetics of Clozapine N-Oxide and Clozapine N-Oxide Hydrochloride Salt in Rhesus Macaques
    Daicia C. Allen, Timothy L. Carlson, Yan Xiong, Jian Jin, Kathleen A. Grant and Verginia C. Cuzon Carlson
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 199-207; DOI: https://doi.org/10.1124/jpet.118.252031
  • You have access
    Inhibitory Effects of Mas-Related Gene C Receptor on Chronic Morphine-Induced Spinal Glial Activation in Rats
    Yunshan Zhang, Mei Wang, Qiuhua Lu, Qi Li, Mingyan Lin, Jianzhong Huang and Yanguo Hong
    Journal of Pharmacology and Experimental Therapeutics February 2019, 368 (2) 237-245; DOI: https://doi.org/10.1124/jpet.118.252494
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 368 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 368, Issue 2
1 Feb 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireviews
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Drug Discovery and Translational Medicine
  • Endocrine and Diabetes
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics